Silvia Squillace

6PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesNanotoxicology, health and safetyNeurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 03, 2025
Contribution of S1pr1 -featured astrocyte subpopulation to cisplatin-induced neuropathic pain in male mice.

Ying Li, Silvia Squillace, Rachel Schafer

|Aug 04, 2025
Ozanimod, a functional sphingosine-1-phosphate receptor 1 antagonist, restores brainstem descending pain pathways in murine models of neuropathic pain.

Luigino Antonio Giancotti, Silvia Squillace, Zhomou Chen

|Oct 02, 2024
CARTp/GPR160 mediates behavioral hypersensitivities in mice through NOD2.

Rachel M Schafer, Luigino A Giancotti, John C Chrivia

|Jan 10, 2024
Behavioral characterization of G-protein-coupled receptor 160 knockout mice.

Rachel M Schafer, Luigino A Giancotti, Daniel J Davis

|Jun 19, 2021
Nitroxidative stress in pain and opioid-induced adverse effects: therapeutic opportunities.

Silvia Squillace, Daniela Salvemini

|May 10, 2019
Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain.

Zhoumou Chen, Timothy M Doyle, Livio Luongo

Pageof 1

Frequent Collaborators

1 joint publications

Thomas A Kufer

1 joint publications

Timothy M Doyle

1 joint publications

Alexander Pendleton